|
VERA Vera Therapeutics, Inc 1831828 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-109,473,000.00 |
| Balance Sheet |
|
Current Assets
|
$527,493,000.00 |
|
Assets
|
$532,984,000.00 |
|
Current Liabilities
|
$48,321,000.00 |
|
Liabilities
|
$125,226,000.00 |
|
Equity
|
$407,758,000.00 |
|
Shares Out
|
72063335.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-206,753,000.00 |
|
Investing Cash Flow
|
$-104,956,000.00 |
| Market Analysis |
Market Cap
|
$2,252,699,852.10 |
|
Price
|
$34.00 |
|
BVPS
|
5.66 |
|
PB
|
5.52 |
|
EPS
|
-1.52 |
|
FCF
|
$-206,776,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:29 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:19 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-4.66 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
-1.69 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-05 |
-1.20 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-1.26 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VERA documents filed with the SEC.
VERA Filings
Clear
